|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Opal, S.M. (2003) Clinical trial design and outcomes in patients with severe sepsis. Shock 20, 295-302. Polderman, K.H., and Girbes, A.R. (2004) Drug intervention trials in sepsis: divergent results. Lancet 363, 1721-3. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., and Medzhitov R. (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229-41. Reumaux, D., Duthilleul, P., and Roos, D. (2004) Pathogenesis of diseases associated with antineutrophil cytoplasm autoantibodies. Hum. Immunol. 65, 1-12. Rice, L., Orlow, D., Ceonzo, K., Stahl, G.L., Tzianabos, A.O., Wada, H., Aird, W.C., and Buras, J.A. (2005) CpG oligodeoxynucleotide protection in polymicrobial sepsis is dependent on interleukin-17. J. Infect. Dis. 191, 1368-76. Rossignol, D.P., and Lynn, M. (2005) TLR4 antagonists for endotoxemia and beyond. Curr. Opin. Investig. Drugs 6(5), 496-502. Smith, K.D., and Bolouri, H. (2005) Dissecting innate immune responses with the tools of systems biology. Curr. Opin. Immunol. 17, 49-54. Tracey, K.J., Czura, C.J., and Ivanova, S. (2001) Mind over immunity. FASEB J. 15, 1575-6. Tzianabos, A.O., and Kasper, D.L. (2002) Role of T cells in abscess formation. Curr. Opin. Microbiol. 5, 92-6. Wiendl, H., and Hohlfeld, R. (2002) Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials. BioDrugs 16, 183-200. Wilson M. (2005) Microbial Inhabitants of Humans. Cambridge, UK: Cambridge University Press.
|
|
|||||||||||||||
